Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors’ Target Prediction

<div>Biological process dot plot of the top 10 GO terms of 169 putative pleiotropic genes and 21 potential pleiotropic therapeutic targets for SGLT2 inhibitors.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors’ Target Prediction 

Figure 5 | Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors’ Target Prediction 